GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Valneva SE (XPAR:VLA) » Definitions » Total Long-Term Liabilities

Valneva SE (XPAR:VLA) Total Long-Term Liabilities : €190.0 Mil (As of Sep. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Valneva SE Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. Valneva SE's Total Long-Term Liabilities for the quarter that ended in Sep. 2024 was €190.0 Mil.

Valneva SE Total Long-Term Liabilities Historical Data

The historical data trend for Valneva SE's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valneva SE Total Long-Term Liabilities Chart

Valneva SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 88.27 195.87 277.79 124.15 172.95

Valneva SE Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 144.87 172.95 197.51 197.80 189.99

Valneva SE Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

Valneva SE Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Valneva SE's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Valneva SE Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Valneva SE (XPAR:VLA) » Definitions » Total Long-Term Liabilities
Comparable Companies
XPAR:GNFT XPAR:OSE XPAR:ALSEN XPAR:ALCLS XPAR:NANO XPAR:MEDCL XPAR:ABVX XPAR:IVA XPAR:ADOC XPAR:IPH VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY BNTX XKRX:068270 BGNE
Traded in Other Exchanges
VALN:USA INRLF:USA VLAp:UK 0OB3:UK AYJ:Germany AYJ0:Germany AYJ0:Germany AYJ:Germany AYJ:Germany AYJ:Germany AYJ:Bulgaria VLA:Austria
Address
6 Rue Alain Bombard, Saint-Herblain, FRA, 44800
Website
https://www.valneva.com
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates the majority of its revenue from product sales.

Valneva SE Headlines

No Headlines